Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms

The deregulated DLX gene family members DLX1/2/3/4/5/6 (DLXs) caused by DNA methylation has been demonstrated in various cancers with therapeutic target value. However, the potential role of DLXs methylation in myeloid neoplasms such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ting‐juan, Xu, Zi‐jun, Gu, Yu, Wen, Xiang‐mei, Ma, Ji‐chun, Zhang, Wei, Deng, Zhao‐qun, Leng, Jia‐yan, Qian, Jun, Lin, Jiang, Zhou, Jing‐dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403826/
https://www.ncbi.nlm.nih.gov/pubmed/32508046
http://dx.doi.org/10.1002/ctm2.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403826/
https://www.ncbi.nlm.nih.gov/pubmed/32508046
http://dx.doi.org/10.1002/ctm2.29

Ejemplares similares